Chargement en cours...
Repurposing carbamazepine for the treatment of amyotrophic lateral sclerosis in SOD1‐G93A mouse model
AIMS: To investigate the effect and mechanisms of carbamazepine (CBZ) on the onset and progression of amyotrophic lateral sclerosis (ALS) in SOD1‐G93A mouse model. METHODS: Starting from 64 days of age, SOD1‐G93A mice were orally administered with CBZ at 200 mg/kg once daily until death. The disease...
Enregistré dans:
| Publié dans: | CNS Neurosci Ther |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6489874/ https://ncbi.nlm.nih.gov/pubmed/29656576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12855 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|